
Mohs dermatologists and other surgeons should collaborate in the treatment of patients with squamous cell carcinoma to improve patient survival and recurrence rates, according to an expert who presented an outcomes poster at the annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery Foundation.
